Complete Filing Data
Microvast Holdings, Inc. reported Profit Loss of -$29.22 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Microvast Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$29.2M | -$195.5M | -$106.3M | -$158.2M | -$206.5M | $1.4M | $3.4M |
| Revenue * | $427.5M | $379.8M | $306.6M | $204.5M | $152.0M | $107.5M | $76.4M |
| Operating Income Loss | $7.0M | -$116.1M | -$106.7M | -$159.9M | -$194.1M | -$29.1M | -$53.9M |
| Income Tax Expense Benefit | -$5.3M | $0.00 | $10.0K | $33.0K | $0.00 | $1.0K | $189.0K |
| Operating Expenses | $118.3M | $238.3M | $165.9M | $170.7M | $157.4M | $49.2M | $56.9M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$34.5M | -$195.5M | -$106.4M | -$158.2M | -$206.5M | -$33.6M | -$59.5M |
| Selling And Marketing Expense | $22.2M | $22.6M | $23.6M | $22.6M | $21.4M | $13.8M | $15.7M |
| Research And Development Expense | $34.1M | $41.1M | $45.0M | $43.5M | $34.4M | $16.6M | $26.0M |
| Nonoperating Income Expense | $244.0K | $156.0K | -$713.0K | $944.0K | -$62.0K | $650.0K | -$145.0K |
| Gross Profit | $122.1M | $119.6M | $57.2M | $9.1M | -$42.7M | $17.1M | -$231.0K |
| General And Administrative Expense | $57.8M | $81.5M | $96.8M | $102.8M | $101.6M | $18.8M | $15.2M |
| Cost Of Revenue | $260.2M | $249.4M | $195.4M | $194.7M | $90.4M | $76.7M | |
| Comprehensive Income Net Of Tax | -$8.2M | -$208.0M | -$113.9M | -$183.0M | -$207.1M | -$33.6M | -$59.7M |
| Interest Expense | $2.6M | $3.3M | $5.4M | $5.7M | $6.4M | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$8.2M | -$208.0M | -$114.0M | -$183.0M | -$207.1M | ||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | -$24.8M | -$655.0K | $16.6M | -$3.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.5M | -$106.1M | $61.8M | $13.2M | -$101.6M | -$24.8M | -$26.1M | -$26.1M | -$29.6M | -$36.5M | -$44.2M | -$43.8M | -$116.5M | -$2.1M | -$48.8K | -$101.3K | -$297.2K | $1.9M | $1.3M | $1.3M | $283.3K | -$792.00 |
| Revenue * | $123.3M | $91.3M | $116.5M | $101.4M | $83.7M | $81.4M | $80.1M | $75.0M | $47.0M | $38.6M | $64.4M | $36.7M | $36.9M | $33.4M | $14.9M | $30.8M | ||||||
| Operating Income Loss | $13.0M | $16.2M | $18.9M | $7.2M | -$98.7M | -$23.1M | -$26.3M | -$26.9M | -$31.3M | -$37.1M | -$45.0M | -$43.3M | -$113.3M | -$22.3M | -$10.8M | -$9.1M | -$251.7K | -$228.7K | -$262.3K | -$195.4K | -$70.0K | -$792.00 |
| Income Tax Expense Benefit | $739.0K | $220.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $106.0K | $109.0K | $109.0K | -$270.0K | -$43.4K | $470.6K | $231.1K | $343.6K | $75.3K | |
| Operating Expenses | $33.5M | $16.5M | $25.5M | $27.5M | $126.7M | $40.9M | $44.7M | $39.0M | $36.2M | $39.6M | $50.4M | $43.4M | $78.0M | $15.8M | $11.5M | $12.7M | $251.7K | $262.3K | $195.4K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$750.0K | -$105.8M | $61.8M | $13.2M | -$101.6M | -$24.8M | -$26.2M | -$26.1M | -$29.6M | -$36.5M | -$44.2M | -$43.8M | -$116.4M | -$27.0M | -$16.2M | -$10.4M | -$340.5K | |||||
| Selling And Marketing Expense | $6.0M | $3.4M | $6.8M | $5.0M | $5.0M | $5.6M | $6.0M | $5.9M | $5.0M | $5.6M | $5.8M | $6.0M | $7.4M | $3.7M | $3.2M | $3.5M | ||||||
| Research And Development Expense | $7.8M | $7.7M | $8.2M | $10.7M | $10.1M | $11.5M | $13.2M | $9.5M | $10.9M | $11.5M | $10.2M | $11.3M | $13.5M | $5.9M | $3.8M | $4.6M | ||||||
| Nonoperating Income Expense | -$84.0K | $120.0K | $320.0K | -$310.0K | $153.0K | -$136.0K | $127.0K | -$243.0K | $789.0K | $349.0K | $10.0K | $399.0K | -$19.0K | $49.0K | -$5.0K | $68.0K | ||||||
| Gross Profit | $46.4M | $31.7M | $43.0M | $33.6M | $27.2M | $17.2M | $17.9M | $11.5M | $4.9M | $2.0M | $4.8M | $13.0K | -$35.9M | -$6.8M | -$1.2M | $3.7M | ||||||
| General And Administrative Expense | $19.7M | $4.0M | $10.5M | $11.8M | $23.5M | $23.8M | $25.0M | $23.5M | $20.4M | $22.6M | $34.3M | $26.1M | $57.1M | $6.2M | $4.6M | $4.7M | ||||||
| Cost Of Revenue | $76.9M | $59.6M | $73.5M | $67.8M | $56.5M | $64.1M | $62.2M | $63.5M | $42.1M | $36.6M | $59.6M | $36.7M | $72.8M | $40.1M | $16.2M | $27.1M | ||||||
| Comprehensive Income Net Of Tax | $1.2M | -$99.0M | $65.6M | $24.7M | -$104.1M | -$29.9M | -$28.3M | -$44.0M | -$27.4M | -$57.5M | -$61.8M | -$42.8M | -$119.6M | -$23.4M | -$19.2M | $778.0K | ||||||
| Interest Expense | $1.7M | $491.0K | $487.0K | $459.0K | $774.0K | $895.0K | $796.0K | $1.2M | $1.5M | $1.8M | $1.4M | |||||||||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.2M | -$99.0M | $65.6M | $24.7M | -$104.1M | -$29.9M | -$28.4M | -$44.1M | -$27.4M | -$57.5M | -$61.8M | -$42.8M | ||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax | $986.0K | -$3.1M | -$2.9M | $10.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $410.5M | $387.9M | $564.2M | $613.0M | $686.7M | -$384.6M | -$320.3M | -$266.6M |
| Cash And Cash Equivalents At Carrying Value | $105.0M | $73.0M | $44.5M | $231.4M | $480.9M | $21.5M | $17.5K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | ||||||||
| Temporary Equity Foreign Currency Translation Adjustments | $21.0M | -$12.6M | -$7.6M | -$24.8M | -$655.0K | $16.6M | -$3.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $59.6M | $21.4M | -$214.4M | -$233.5M | $494.9M | -$588.0K | -$43.8M | |
| Retained Earnings Accumulated Deficit | -$1.12B | -$1.09B | -$897.5M | -$791.2M | -$632.1M | -$398.0M | $3.4M | -$792.00 |
| Prepaid Expense And Other Assets Current | $17.2M | $27.0M | $25.8M | $12.1M | $17.1M | $6.0M | $186.2K | $25.00 |
| Liabilities And Stockholders Equity | $1.01B | $951.9M | $1.10B | $985.0M | $995.3M | $404.5M | $280.5M | $101.2K |
| Assets Current | $448.7M | $428.0M | $425.6M | $545.1M | $706.6M | $189.3M | $396.4K | $17.5K |
| Assets | $1.01B | $951.9M | $1.10B | $985.0M | $995.3M | $404.5M | $280.5M | $101.2K |
| Liabilities Current | $488.3M | $330.2M | $403.4M | $252.4M | $175.6M | $183.6M | $269.1K | $75.8K |
| Repayments Of Bank Debt | $96.1M | $66.2M | $14.1M | $24.5M | $37.6M | $17.8M | $71.7M | |
| Repayments Of Related Party Debt | $0.00 | $0.00 | $8.4M | $18.9M | $15.1M | |||
| Liabilities | $594.9M | $564.0M | $532.5M | $372.0M | $308.6M | $389.2M | $296.1K | $75.8K |
| Common Stock Value | $34.0K | $33.0K | $32.0K | $31.0K | $30.0K | $6.0K | $836.00 | $720.00 |
| Restricted Cash Current | $64.3M | $36.6M | $37.5M | $70.7M | $55.2M | $19.7M | ||
| Other Liabilities Noncurrent | $37.1M | $30.0M | $24.9M | $32.1M | $39.8M | $110.6M | ||
| Other Assets Noncurrent | $12.2M | $14.0M | $9.7M | $73.6M | $19.7M | $890.0K | ||
| Notes Payable Current | $78.3M | $51.8M | $63.4M | $68.4M | $61.0M | $35.8M | ||
| Inventory Net | $89.4M | $143.3M | $149.7M | $84.3M | $53.4M | $45.0M | ||
| Intangible Assets Net Excluding Goodwill | $2.2M | $2.6M | $3.1M | $1.6M | $1.9M | $2.3M | ||
| Allowance For Doubtful Accounts Receivable Current | $4.7M | $5.1M | $4.6M | $4.4M | $5.0M | $5.0M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$17.2M | -$38.2M | -$25.6M | -$18.1M | $6.7M | $7.4M | ||
| Accounts Payable Current | $47.0M | $64.9M | $112.6M | $45.0M | $40.4M | $42.0M | ||
| Operating Lease Right Of Use Asset | $17.3M | $17.6M | $19.5M | $16.4M | $18.8M | $14.0M | ||
| Property Plant And Equipment Net | $508.1M | $478.2M | $620.7M | $335.1M | $253.1M | $198.0M | ||
| Less Accretion Of Series C2Preferred Stock | $0.00 | $0.00 | $5.1M | $8.9M | $7.9M | |||
| Amortization Of Land Use Right And Intangible Assets |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $358.1M | $356.1M | $454.2M | $486.1M | $455.0M | $546.1M | $565.3M | $577.7M | $603.7M | $613.0M | $615.9M | $654.0M | $657.4M | $716.8M | -$6.5M | -$4.5M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | $5.0M | ||||
| Cash And Cash Equivalents At Carrying Value | $90.7M | $99.7M | $90.9M | $63.6M | $68.2M | $39.5M | $67.4M | $142.8M | $200.3M | $295.8M | $333.9M | $416.2M | $572.6M | $13.4M | $9.6M | $255.9K | $144.5K | $196.0K | $140.3K | $440.8K | $1.0M | $809.1K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $142.6M | $138.8M | $123.0M | $109.6M | $115.0M | $104.5M | $86.7M | $88.2M | $89.2M | $170.3M | $260.5M | $302.6M | $415.7M | $396.9M | $470.7M | $536.1M | $612.5M | $33.8M | $37.8M | $41.2M | $31.3M | $41.8M | |||||
| Temporary Equity Foreign Currency Translation Adjustments | $2.7M | $7.1M | $3.8M | $11.5M | -$2.5M | -$5.1M | -$2.2M | -$18.0M | $2.2M | -$21.0M | -$17.6M | $986.0K | -$3.1M | $3.7M | -$2.9M | $10.9M | |||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $13.4M | -$1.5M | -$42.1M | -$65.4M | -$3.4M | ||||||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.14B | -$1.14B | -$1.03B | -$987.5M | -$1.00B | -$922.3M | -$873.0M | -$846.8M | -$820.7M | -$757.5M | -$720.9M | -$676.7M | -$585.5M | -$6.5M | -$4.5M | $4.9M | $5.0M | $5.0M | $2.4M | $1.5M | $282.5K | ||||||
| Prepaid Expense And Other Assets Current | $24.9M | $19.9M | $30.0M | $23.5M | $16.7M | $21.0M | $25.8M | $20.6M | $13.5M | $19.1M | $14.5M | $19.7M | $13.0M | $39.5K | $18.8K | $87.9K | $156.2K | $216.1K | $173.8K | $170.3K | $23.1K | ||||||
| Liabilities And Stockholders Equity | $1.01B | $1.00B | $982.9M | $1.02B | $984.6M | $1.04B | $1.02B | $997.7M | $1.00B | $972.9M | $971.6M | $998.7M | $990.4M | $281.8M | $282.4M | $282.5M | $282.6M | $282.8M | $279.6M | $279.0M | $277.3M | ||||||
| Assets Current | $445.3M | $434.6M | $448.0M | $437.6M | $418.0M | $378.2M | $403.9M | $427.0M | $497.0M | $567.5M | $611.4M | $653.2M | $750.9M | $106.0K | $62.9K | $343.8K | $300.6K | $412.1K | $677.2K | $1.2M | $832.2K | ||||||
| Assets | $1.01B | $1.00B | $982.9M | $1.02B | $984.6M | $1.04B | $1.02B | $997.7M | $1.00B | $972.9M | $971.6M | $998.7M | $990.4M | $281.8M | $282.4M | $282.5M | $282.6M | $282.8M | $279.6M | $279.0M | $277.3M | ||||||
| Liabilities Current | $530.0M | $524.7M | $339.9M | $335.9M | $372.5M | $366.6M | $336.4M | $292.7M | $277.8M | $231.8M | $226.3M | $181.4M | $153.6M | $801.5K | $941.1K | $626.1K | $456.6K | $543.5K | $543.7K | $137.2K | |||||||
| Repayments Of Bank Debt | $13.1M | $12.5M | $0.00 | $0.00 | $12.3M | ||||||||||||||||||||||
| Repayments Of Related Party Debt | $0.00 | $4.2M | $86.7K | ||||||||||||||||||||||||
| Liabilities | $655.5M | $648.6M | $528.7M | $511.8M | $506.5M | $494.5M | $449.2M | $418.0M | $398.2M | $357.1M | $317.6M | $341.3M | $273.6M | $6.7M | $5.1M | $826.1K | $761.6K | $845.6K | $305.9K | $575.7K | $141.3K | ||||||
| Common Stock Value | $33.0K | $33.0K | $33.0K | $33.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K | $31.0K | $30.0K | $30.0K | $30.0K | $789.00 | $789.00 | $838.00 | $839.00 | $840.00 | $833.00 | $827.00 | $830.00 | ||||||
| Restricted Cash Current | $51.9M | $39.1M | $32.1M | $40.4M | $34.7M | $44.7M | $21.8M | $27.5M | $60.2M | $83.2M | $63.1M | $54.6M | $39.9M | $20.5M | $28.2M | ||||||||||||
| Other Liabilities Noncurrent | $34.0M | $31.8M | $29.8M | $38.5M | $26.7M | $25.2M | $20.8M | $32.0M | $31.3M | $29.6M | $32.2M | $36.2M | $35.5M | ||||||||||||||
| Other Assets Noncurrent | $12.5M | $15.3M | $17.7M | $11.1M | $11.5M | $10.0M | $28.5M | $36.6M | $29.1M | $52.8M | $49.8M | $40.1M | $702.0K | ||||||||||||||
| Notes Payable Current | $57.2M | $43.8M | $47.9M | $56.3M | $48.4M | $63.4M | $39.3M | $50.1M | $67.8M | $72.8M | $76.6M | $70.7M | $43.1M | ||||||||||||||
| Inventory Net | $126.9M | $141.7M | $129.1M | $157.8M | $152.5M | $137.3M | $126.9M | $86.8M | $87.7M | $82.3M | $64.5M | $58.1M | $47.8M | ||||||||||||||
| Intangible Assets Net Excluding Goodwill | $2.3M | $2.4M | $2.5M | $2.8M | $2.9M | $3.0M | $3.2M | $3.3M | $3.7M | $1.7M | $1.8M | $1.8M | $2.0M | ||||||||||||||
| Allowance For Doubtful Accounts Receivable Current | $5.2M | $6.4M | $6.5M | $3.8M | $4.7M | $5.1M | $3.2M | $3.5M | $3.3M | $5.4M | $5.8M | $5.4M | $4.8M | ||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$24.5M | -$27.2M | -$34.3M | -$21.8M | -$33.2M | -$30.7M | -$35.9M | -$33.7M | -$15.9M | -$30.9M | -$9.9M | $7.7M | $5.0M | ||||||||||||||
| Accounts Payable Current | $59.8M | $72.5M | $56.8M | $65.6M | $79.9M | $83.1M | $95.3M | $54.3M | $41.2M | $36.0M | $39.6M | $32.0M | $36.6M | ||||||||||||||
| Operating Lease Right Of Use Asset | $18.1M | $19.0M | $18.2M | $19.5M | $19.6M | $18.8M | $19.6M | $21.0M | $18.5M | $15.5M | $17.1M | $18.4M | $13.9M | ||||||||||||||
| Property Plant And Equipment Net | $524.0M | $522.0M | $485.2M | $527.2M | $519.4M | $616.5M | $549.5M | $497.8M | $443.1M | $286.3M | $278.4M | $271.2M | $222.8M | ||||||||||||||
| Less Accretion Of Series C2Preferred Stock | $0.00 | $0.00 | $0.00 | $570.0K | $2.3M | $2.3M | $2.2M | ||||||||||||||||||||
| Amortization Of Land Use Right And Intangible Assets | $192.0K | $194.0K | $205.0K | $143.0K | $188.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $75.9M | $2.8M | -$75.3M | -$53.9M | -$45.0M | $15.6M | $13.4M |
| Net Cash Provided By Used In Investing Activities | -$16.0M | -$12.2M | -$165.6M | -$175.9M | -$87.9M | -$17.7M | -$4.0M |
| Net Cash Provided By Used In Financing Activities | -$2.7M | $37.6M | $33.0M | $5.0M | $624.9M | -$507.0K | -$52.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$8.9M | -$3.3M | $14.3M | -$3.6M | $11.0M | $1.7M | -$1.4M |
| Payments To Acquire Property Plant And Equipment | $19.8M | $27.7M | $186.8M | $150.9M | $87.9M | $18.6M | $20.3M |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $20.6M | -$16.5M | $6.6M | -$24.7M | -$5.9M | $2.3M | -$1.5M |
| Increase Decrease In Notes Payable | $24.0M | -$9.9M | -$3.5M | $13.5M | $24.2M | -$1.6M | -$25.9M |
| Increase Decrease In Contract With Customer Liability | -$38.3M | $836.0K | -$10.9M | $53.0M | -$971.0K | -$1.4M | $2.3M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.5M | -$6.8M | -$6.6M | -$8.6M | $2.9M | $2.0M | -$994.0K |
| Increase Decrease In Other Noncurrent Assets | -$629.0K | $973.0K | $547.0K | $282.0K | $2.1M | $139.0K | -$280.0K |
| Increase Decrease In Notes Receivables | $27.3M | -$6.5M | $25.3M | -$3.2M | -$10.0M | -$13.9M | -$31.8M |
| Increase Decrease In Inventories | -$27.1M | $546.0K | $74.4M | $43.7M | $25.9M | -$13.6M | -$10.4M |
| Increase Decrease In Accounts Receivable | $27.3M | -$8.8M | $21.8M | $38.9M | $11.8M | $3.6M | -$46.9M |
| Proceeds From Bank Debt | $85.7M | $101.5M | $47.9M | $58.7M | $38.9M | ||
| Increase Decrease In Due To Other Related Parties | -$3.0K | $5.0K | $0.00 | $85.0K | -$84.0K | $1.9M | -$1.2M |
| Share Based Compensation | $3.1M | $30.8M | $65.0M | $90.8M | $82.9M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q1 2024 | Q3 2023 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | $7.2M | -$5.4M | $2.0M | -$29.3M | -$11.2M | -$24.9M | -$2.2M | -$109.9K | -$27.6K | -$342.00 |
| Net Cash Provided By Used In Investing Activities | -$2.3M | -$4.5M | -$35.8M | -$41.1M | -$25.4M | $165.6K | -$276.0M | |||
| Net Cash Provided By Used In Financing Activities | $9.5M | $6.3M | $4.4M | $0.00 | $23.8M | $276.8M | $17.8K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.4M | -$4.3M | $857.0K | $2.6M | $2.7M | $29.8K | $23.1K | |||
| Payments To Acquire Property Plant And Equipment | $2.3M | $10.2M | $35.9M | $41.1M | $25.4M | |||||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | -$6.8M | -$10.6M | -$3.4M | -$6.2M | $178.0K | |||||
| Increase Decrease In Notes Payable | -$4.2M | $1.0M | -$936.0K | $9.4M | $542.0K | |||||
| Increase Decrease In Contract With Customer Liability | $462.0K | -$1.7M | -$1.2M | $2.1M | $203.0K | |||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$907.0K | -$5.3M | $470.0K | $598.0K | $474.0K | |||||
| Increase Decrease In Other Noncurrent Assets | $1.4M | $275.0K | -$288.0K | $51.0K | -$19.0K | |||||
| Increase Decrease In Notes Receivables | $5.3M | -$10.6M | $21.3M | $13.5M | -$3.7M | |||||
| Increase Decrease In Inventories | -$15.8M | -$16.3M | $7.0M | $4.9M | $7.4M | |||||
| Increase Decrease In Accounts Receivable | $14.1M | -$12.0M | -$32.3M | -$8.7M | -$13.8M | |||||
| Proceeds From Bank Debt | $28.2M | $18.8M | $4.4M | $0.00 | $13.4M | |||||
| Increase Decrease In Due To Other Related Parties | -$5.0K | $0.00 | $0.00 | $85.0K | -$175.0K | |||||
| Share Based Compensation | $703.0K | $11.9M | $17.9M | $28.1M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.09 | -$0.61 | -$0.34 | -$0.52 | -$1.26 | -$0.82 | -$1.17 | |
| Common Stock Shares Issued | 333.5M | 324.8M | 316.7M | 309.3M | 300.5M | 99.0M | 8.4M | 7.2M |
| Common Stock Shares Outstanding | 331.8M | 323.1M | 315.0M | 307.6M | 298.8M | 99.0M | 8.4M | 7.2M |
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 240.5M | 65.0M | 65.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 185.9M | 99.0M | 99.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 324.7M | 318.5M | 310.9M | 303.3M | 185.9M | 99.0M | ||
| Earnings Per Share Basic | $-0.09 | $-0.61 | $-0.34 | $-0.52 | $-1.26 | $-0.82 | ||
| Weighted Average Number Of Shares Outstanding Basic | 324.7M | 318.5M | 310.9M | 303.3M | 185.9M | 99.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | -$0.33 | $0.05 | $0.03 | -$0.32 | -$0.08 | -$0.08 | -$0.08 | -$0.10 | -$0.12 | -$0.15 | -$0.15 | -$0.49 | -$0.40 | -$0.29 | -$0.22 | -$0.02 | $0.00 | -$0.02 | -$0.02 | $0.00 | $0.00 |
| Common Stock Shares Issued | 325.5M | 325.4M | 325.2M | 323.8M | 317.2M | 317.2M | 316.5M | 309.6M | 309.4M | 309.3M | 302.5M | 300.5M | 300.5M | 7.9M | 7.9M | 8.4M | 8.4M | 8.4M | 8.3M | 8.3M | 8.3M | |
| Common Stock Shares Outstanding | 323.8M | 323.7M | 323.5M | 322.1M | 315.5M | 315.5M | 314.8M | 307.9M | 307.7M | 307.6M | 300.9M | 298.9M | 298.8M | 7.9M | 7.9M | 8.4M | 8.4M | 8.4M | 8.3M | 8.3M | 8.3M | |
| Common Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | 65.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 243.9M | 27.6M | 26.7M | 99.0M | 27.1M | 27.1M | 8.3M | 8.3M | 6.8M | 6.3M | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 323.8M | 323.6M | 374.4M | 367.0M | 315.5M | 315.4M | 313.1M | 307.7M | 307.7M | 306.0M | 300.6M | 298.8M | 243.9M | 99.0M | 99.0M | 8.4M | ||||||
| Earnings Per Share Basic | $0.00 | $-0.33 | $0.19 | $0.04 | $-0.32 | $-0.08 | $-0.08 | $-0.08 | $-0.10 | $-0.12 | $-0.15 | $-0.15 | $-0.49 | $-0.40 | $-0.29 | $0.00 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 323.8M | 323.6M | 323.4M | 320.5M | 315.5M | 315.4M | 313.1M | 307.7M | 307.7M | 306.0M | 300.6M | 298.8M | 243.9M | 99.0M | 99.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Subsidy Income | $3.1M | $2.7M | $2.0M | $1.7M | $6.1M | $3.0M | $3.2M | |
| Interest Income | $957.0K | $742.0K | $3.6M | $3.2M | $446.0K | $571.0K | $884.0K | |
| Provision For Doubtful Accounts | $3.7M | $236.0K | $1.6M | $721.0K | -$240.0K | -$4.3M | ||
| Product Warranty Expense | $17.2M | $12.8M | $12.7M | $14.1M | $52.9M | $3.5M | $3.5M | |
| Provision For Obsolete Inventories | $33.7M | $3.3M | $3.6M | $4.8M | $18.3M | $1.3M | $4.2M | |
| Depreciation Nonproduction | $32.4M | $30.1M | $22.1M | $19.8M | $20.0M | $16.1M | $14.7M | |
| Additional Paid In Capital | $1.54B | $1.51B | $1.48B | $1.42B | $1.31B | $1.6M | $25.5K | |
| Net Loss Attributable To Ordinary Shareholders Of Microvast Inc | -$106.3M | -$158.2M | -$234.1M | -$81.0M | -$115.5M | |||
| Statutory Accounting Practices Statutory Capital And Surplus Balance | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Subsidy Income | $44.0K | $995.0K | $1.4M | $1.1M | $735.0K | $534.0K | $442.0K | $637.0K | $77.0K | $520.0K | $576.0K | $137.0K | $545.0K | $213.0K | $1.9M | -$39.0K | |||||
| Interest Income | $236.0K | $198.0K | $177.0K | $186.0K | $246.0K | $119.0K | $582.0K | $1.5M | $1.4M | $870.0K | $420.0K | $314.0K | $97.0K | $111.0K | $96.0K | $66.0K | |||||
| Provision For Doubtful Accounts | -$347.0K | $833.0K | $1.4M | -$992.0K | $177.0K | $578.0K | -$206.0K | $262.0K | -$1.1M | -$43.0K | $925.0K | -$545.0K | $457.0K | -$514.0K | |||||||
| Product Warranty Expense | $4.8M | $3.3M | $2.5M | $2.7M | $909.0K | ||||||||||||||||
| Provision For Obsolete Inventories | $0.00 | $471.0K | $218.0K | ||||||||||||||||||
| Depreciation Nonproduction | $8.0M | $7.5M | $4.9M | $5.3M | |||||||||||||||||
| Additional Paid In Capital | $1.52B | $1.51B | $1.51B | $1.51B | $1.51B | $1.49B | $1.47B | $1.45B | $1.43B | $1.40B | $1.38B | $1.32B | $1.29B | $4.0M | $131.2K | $29.9K | $2.6M | $3.5M | $4.7M | ||
| Net Loss Attributable To Ordinary Shareholders Of Microvast Inc | -$36.5M | -$44.2M | -$43.8M | -$120.0M | -$39.1M | -$28.3M | -$21.9M | ||||||||||||||
| Statutory Accounting Practices Statutory Capital And Surplus Balance | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M | $6.0M |
Most recent annual filing with the SEC: March 16, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.